Life Science Factory’s Post

In this GlovesOff episode, we're chatting with Josh Makower, a rockstar in #medical andbioengineering innovation. He teaches at #StanfordUniversity and helped kick off the Stanford Byers Center for #Biodesign, so you know he's leading the charge in #medicalbreakthroughs. Plus, he's the brain behind #ExploraMed, a medical device incubator that's launched 10 companies in just 20 years, advises #PatientSquareCapital, and lends his wisdom to a bunch of company boards. With 300 patents under his belt, his work has made waves in everything from #cardiology to #surgery and #drugdelivery. We're diving into Dr. Makower's thoughts on #innovation, the future of #bioengineering, and how #medicaldevices are changing the game. This episode is a must for anyone curious about where #medicine, #technology, and #entrepreneurship meet.

🎤 💡 👨🔬 🦻 In our first TRAIN Academy Keynote Lecture of 2025, Daniel Keppeler explained how optical cochlear implants could fundamentally revolutionize the hearing perception of deaf and hearing-impaired people. He showed the groundbreaking technology behind it, which will significantly enhance the quality of hearing with an implant. He also elaborated on the challenging transformation from a researcher to one of the leaders of the start-up OptoGenTech GmbH. The foundation of OptoGenTech GmbH is based on research work at the Universitätsmedizin Göttingen, the Deutsches Primatenzentrum GmbH in Göttingen, the Albert-Ludwigs-Universität Freiburg and the Technische Universität Chemnitz as well as the seed funding of Photonik Inkubator GmbH Göttingen. 🔦 🧬 🔬 🧪 The approach of using photonic methods to improve hearing has developed rapidly in recent years. Daniel gave us an overview of the current state of research, focusing on the optical control of genetically modified cells. This innovative technology has the potential to advance life sciences in various fields beyond hearing restoration. 💡💰 💁♀️ 🙋 His presentation offered a valuable glimpse into the critical aspects of founding a life science start-up, particularly the challenges of financing it from start to finish. OptoGenTech GmbH faced hurdles when seeking investors, as many were only willing to engage at a more advanced stage. Daniel emphasized the importance of support from accelerators or incubators, which provided essential guidance during the company's foundational steps. Moreover, an engaged start-up team and an experienced project manager among others played a key role in overcoming initial obstacles. 🧑💻 📳 📈 Daniel also shared insights into the diverse responsibilities of leading a start-up as CEO, where decision-making spans all areas of the business. This requires not only expertise but also a willingness to take calculated risks. 🎤 🤝 🍹 The success of OptoGenTech GmbH has been reached by networking at events like the TRAIN Academy Keynote Lecture. Direct discussions and connections at such gatherings have provided crucial ideas and support, enabling the company to make remarkable progress. 🦻 👏 ✨ OptoGenTech GmbH aims to launch the optical cochlear implant (oCI) by 2036. We extend our best wishes to Daniel and his team as they continue on this inspiring journey! #LifeScience #Research #Science #Translation #Startup #Optogenetics #OptoGenTechGmbH

The present decade is the most exciting time for nanorobotics! Recent breakthroughs, like magnetically guided nanobots for precise cancer drug delivery, are revolutionizing medicine

Axoft's high-density electrode design is reshaping how we communicate with the nervous system. With a density 1,000 times higher than current soft probes, Axoft's technology allows for high-resolution neural communication without compromising biocompatibility. This leads to improved stability and reduced tissue damage over time. 📊 Data shows Axoft's implant is 10,000 times softer than existing flexible electronics, demonstrating long-term signal stability and the ability to track single neurons for over a year. 🔍 Practical Tip: For medtech innovators, partnering with a Medtech-only CRO like bioaccess® is key to navigating the regulatory and operational complexities of clinical trials in Latin America. This collaboration is vital for startups like Axoft to conduct successful early feasibility studies. Stay informed, stay innovative! #Neurotechnology #ClinicalTrials https://lnkd.in/ePj74h8f

Parents usually want their children to follow in their footsteps. But sometimes life takes a different turn. In my case, I wasn't "Nalayak" but my love for maths and physics led me to Biotechnology, Medical devices, and Life Sciences. Today, I got to experience the best of both worlds! I was able to observe our Laparoscopy tower in live surgery, and it was an amazing feeling to see our product performing well and being praised by the doctors. I might not have become a doctor, but I now have a hang of both sides! Above all it's good to innovate a world class medical device & get satisfied customers. That's the real high ! #biotechnology #lifesciences #meddevices #entrepreneurship #businessmanagement #careeropportunities #healthcareindustry UnivLabs Technologies Pvt Ltd

In 2024, Xenco Medical introduced the TrabeculeX Continuum, a pioneering integration of regenerative biomaterials with digital health technologies. This innovation combines a biomaterial engineered to promote 3D bone formation with a remote therapeutic monitoring app, facilitating virtual physical therapy and patient engagement. The TrabeculeX Continuum represents a significant advancement in medical device engineering, aiming to create a seamless link from surgery to full mobility by merging orthobiologics with AI-enabled rehabilitation protocols. Medical's going automated, and, we're ready!!

I have never been involved specifically in optical medical businesses but find the market really interesting, global and large. Thought u might enjoy a short review of something in the space. In the ever-evolving field of medical technology, exciting advancements are being made in eye care. A recent survey by MedTech Innovator highlights three promising startups tackling some of the most challenging degenerative eye diseases. First, Avisi Technologies is pioneering the use of nanotechnology to develop solutions for a wider range of patients suffering from these conditions. This innovative approach has the potential to revolutionize treatment options. Opharmic Technologies is another company pushing boundaries with their utilization of quantum dots. Their research holds the promise of significant breakthroughs in ophthalmic applications, offering new hope for patients battling these debilitating diseases. Finally, 2C Tech is taking a unique approach by leveraging low-frequency ultrasound technology. This novel approach has the potential to significantly improve treatment options and patient outcomes in eye care. These three startups, all participants in the MedTech Innovator accelerator program, offer a glimpse into the exciting future of ophthalmology. Their dedication to innovation could lead to improved quality of life for millions of people struggling with degenerative eye diseases. Read more here, and see below on why solutions for vision impairment are becoming increasingly important: https://lnkd.in/gqqBtKaM #MedTech #Innovation

Medical device startup Fluid Biomed Inc. has secured $27M in Series A funding to fuel the development of its innovative stent for brain aneurysms. Fluid Biomed’s flow-diverting brain stent is constructed of bioabsorbable polymer and metal, a move away from stents traditionally made purely of metal that would stay in the body indefinitely. #BuildSomethingMassive

1. Researchers at University College London developed a device called BAMH that mimics human touch to enable long-distance interactions. 2. The device can potentially be used in robot-assisted surgeries to evaluate tissue types, including detecting cancerous tissues. 3. BAMH stimulates nerve cells through vibrations, simulating realistic touch sensations. 4. The technology may serve as a diagnostic tool for conditions like metacarpal tunnel syndrome and diabetes, which affect touch sensitivity. 5. The device includes a silicone fingertip linked to a machine, providing a realistic sense of touch by stimulating key sensory nerve cells. 6. Researchers plan to conduct clinical trials with individuals experiencing loss of sensation to study touch degradation over time. 7. Advanced versions of the device, such as gloves, could assist in safely handling hazardous materials, like in nuclear waste decommissioning. 8. The technology was presented at the British Science Festival, highlighting its potential applications in healthcare and other fields.

Medical Design & Outsourcing editor Jim Hammerand speaks with our CEO Carolina Aguilar about graphene-based #BCI technology and its unique advantages. 🧠🧠 “In this field, there is a race to put as many contacts as you want or you think you need,” Aguilar said. “.. But I think it’s not about who can put more contacts on the surface of the brain. It’s more about what those contacts can do clinically in a relevant and meaningful way for the patient. We can not forget about that, because this is not a technology race.” Read the article: 👇👇 https://lnkd.in/evr7HGNk